SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001099910-24-000270
Filing Date
2024-07-11
Accepted
2024-07-11 16:51:05
Documents
14
Period of Report
2024-07-11
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT vcxb-8k.htm   iXBRL 8-K 45043
  Complete submission text file 0001099910-24-000270.txt   277578

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE vcxb-20240711.xsd EX-101.SCH 4305
3 XBRL DEFINITION FILE vcxb-20240711_def.xml EX-101.DEF 27431
4 XBRL LABEL FILE vcxb-20240711_lab.xml EX-101.LAB 38062
5 XBRL PRESENTATION FILE vcxb-20240711_pre.xml EX-101.PRE 26051
16 EXTRACTED XBRL INSTANCE DOCUMENT vcxb-8k_htm.xml XML 7254
Mailing Address 1 WORLD TRADE CENTER FLOOR 85 NEW YORK NY 10007
Business Address 1 WORLD TRADE CENTER FLOOR 85 NEW YORK NY 10007 (212) 257-0069
10X Capital Venture Acquisition Corp. III (Filer) CIK: 0001848948 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41216 | Film No.: 241112520
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)